{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:13:00Z","timestamp":1786119180177,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1097\/cad.0b013e3282f421e9","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T08:03:20Z","timestamp":1236240200000},"page":"295-302","source":"Crossref","is-referenced-by-count":2,"title":["An original administration of ifosfamide given once every other week: a clinical and pharmacological study"],"prefix":"10.1097","volume":"19","author":[{"given":"Wulfran","family":"Cacheux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Gourmel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Alexandre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Germann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Rabillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Duffau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Goldwasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210203","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1200\/JCO.1993.11.7.1269","article-title":"Randomized comparison of doxorubicin alone vs. ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas","volume":"11","author":"Edmonson","year":"1993","journal-title":"J Clin Oncol"},{"key":"R2-8-20210203","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.1995.13.10.2594","article-title":"Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group Study","volume":"13","author":"Loehrer","year":"1995","journal-title":"J Clin Oncol"},{"key":"R3-8-20210203","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1200\/JCO.1998.16.4.1388","article-title":"Phase III randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party","volume":"16","author":"Sculier","year":"1998","journal-title":"J Clin Oncol"},{"key":"R4-8-20210203","first-page":"38","article-title":"Ifosfamide in the treatment of breast cancer","volume":"23","author":"Overmoyer","year":"1996","journal-title":"Semin Oncol"},{"key":"R5-8-20210203","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1200\/JCO.1992.10.2.243","article-title":"Ifosfamide and mesna in previously treated advanced epithelial ovarian cancer: activity in platinum-resistant disease","volume":"10","author":"Markman","year":"1992","journal-title":"J Clin Oncol"},{"key":"R6-8-20210203","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1200\/JCO.1997.15.7.2559","article-title":"Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival","volume":"15","author":"McCaffrey","year":"1997","journal-title":"J Clin Oncol"},{"key":"R7-8-20210203","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1200\/JCO.1990.8.1.170","article-title":"High-dose ifosfamide with mesna uroprotection: a phase I study","volume":"8","author":"Elias","year":"1990","journal-title":"J Clin Oncol"},{"key":"R8-8-20210203","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00280-006-0373-8","article-title":"Variations in schedules of ifosfamide administration: a better understanding of its implications on pharmacokinetics through a randomized cross-over study","volume":"60","author":"Brain","year":"2007","journal-title":"Cancer Chemother Pharmacol"},{"key":"R9-8-20210203","first-page":"5629","article-title":"Differential activation of cyclophosphamide and ifosphamide by cytochromes P-450 2B and 3A in human liver microsomes","volume":"53","author":"Chang","year":"1993","journal-title":"Cancer Res"},{"key":"R10-8-20210203","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000429522","article-title":"Ifosfamide dose and scheduling","volume":"26","author":"Brade","year":"1987","journal-title":"Contr Oncol"},{"key":"R11-8-20210203","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000429525","article-title":"Self induction of cyclophosphamide and ifosfamide metabolism by repeated high-dose treatment","volume":"26","author":"Wagner","year":"1987","journal-title":"Contr Oncol"},{"key":"R12-8-20210203","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00183570","article-title":"Ifosfamide pharmacokinetics","volume":"9","author":"Lewis","year":"1991","journal-title":"Invest New Drugs"},{"key":"R13-8-20210203","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2125.1990.tb03842.x","article-title":"Fractionated ifosfamide therapy produces a time-dependent increase in ifosfamide metabolism","volume":"30","author":"Lewis","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"R14-8-20210203","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0305-7372(85)90011-8","article-title":"Ifosfamide\u2013pharmacology, safety and therapeutic potential","volume":"12","author":"Brade","year":"1985","journal-title":"Cancer Treat Rev"},{"key":"R15-8-20210203","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0378-4347(99)00254-6","article-title":"Determination of 4-hydroxyifosfamide concomitantly with ifosfamide and its dechloroethylated metabolites using gas chromatography and a nitrogen phosphorus-selective detector","volume":"732","author":"Gourmel","year":"1999","journal-title":"J Chromatogr B Biomed Sci Appl"},{"key":"R16-8-20210203","first-page":"796a","article-title":"Randomized phase II study of the EORTC soft tissue and bone sarcoma group comparing two different ifosfamide regimens in chemotherapy untreated advanced soft tissue sarcoma patients","volume":"16","author":"Van Oosterom","year":"1997","journal-title":"Proc Am Soc Clin Oncol"},{"key":"R17-8-20210203","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1023\/A:1008353904351","article-title":"High-dose epirubicin and cyclophosphamide every two weeks as first-line chemotherapy for relapsing metastatic breast cancer patients","volume":"10","author":"Cottu","year":"1999","journal-title":"Ann Oncol"},{"key":"R18-8-20210203","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s002280100322","article-title":"Population pharmacokinetics and exploratory pharmacodynamics of ifosfamide and metabolites after a 72-h continuous infusion in patients with soft tissue sarcoma","volume":"57","author":"Kerbusch","year":"2001","journal-title":"Eur J Clin Pharmacol"},{"key":"R19-8-20210203","first-page":"546a","article-title":"Updated results of a rapidly recycled API-AI regimen followed by surgery and radiotherapy: a highly effective therapy in adults with localized tumors belonging to the Ewings sarcoma family","volume":"18","author":"Le Cesne","year":"1999","journal-title":"Proc Am Soc Clin Oncol"}],"container-title":["Anti-Cancer Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/CAD.0b013e3282f421e9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:44:30Z","timestamp":1786038270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001813-200803000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/cad.0b013e3282f421e9","relation":{},"ISSN":["0959-4973"],"issn-type":[{"value":"0959-4973","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3]]}}}